[1] CRAMER J D, BURTNESS B, LE Q T, et al. The changing therapeutic landscape of head and neck cancer[J]. Nat Rev Clin Oncol, 2019, 16(11):669-683. [2] MCCANN K L, KAVARI S L, BURKHOLDER A B, et al. H/ACA snoRNA levels are regulated during stem cell differentiation[J]. Nucleic Acids Res, 2020,48(15):8686-8703. [3] BHARTIYA D, SCARIA V. Genomic variations in non-coding RNAs: Structure, function and regulation[J]. Genomics, 2016, 107(2/3):59-68. [4] BHARDWAJ V, MANDAL A K A. Next-generation sequencing reveals the role of epigallocatechin-3-gallate in regulating putative novel and known microRNAs which target the MAPK pathway in non-small-cell lung cancer A549 cells[J]. Molecules, 2019, 24(2):368. [5] JAMALI Z, AMINABADI N A, ATTARAN R, et al. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis[J]. Oral Oncol, 2015, 51(4):321-331. [6] 郭拴龙, 张斌, 李莹. MicroRNA-7与肿瘤关系研究进展及在口腔肿瘤中的展望[J]. 口腔医学研究, 2015, 31(12):1261-1263. [7] BRATKOVIČ T, ROGELJ B. Biology and applications of small nucleolar RNAs[J]. Cell Mol Life Sci, 2011,68(23):3843-3851. [8] SONG J, BAI Z, HAN W, et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients[J]. Dig Dis Sci, 2012,57(4):897-904. [9] LIANG J, WEN J, HUANG Z, et al. Small nucleolar RNAs: insight into their function in cancer[J]. Front Oncol, 2019,9: 587. [10]DONG X Y, RODRIGUEZ C, GUO P, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer[J]. Hum Mol Genet, 2008, 17(7):1031-1042. [11]YOSHIDA K, TODEN S, WENG W, et al. SNORA21- an oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer[J]. EBioMedicine, 2017, 22:68-77. [12]BASU S, CHAUDHARY A, CHOWDHURY P, et al. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer[J]. Gene, 2020,730:144264. [13]KIM E J, KIM J S, LEE S, et al. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth[J]. Int J Cancer, 2019, 145(6):1585-1595. [14]CHEN M L, LIANG L S, WANG X K. MiR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1[J]. Clin Exp Metastasis,2012,29(5):457-469. [15]LI A, OMURA N, HONG S M,et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels[J]. Cancer Res, 2010, 70(13):5226-5237. [16]JEVINEK SKOK D, HAUPTMAN N, BOTJANČIČ E, et al. The integrative knowledge base for miRNA-mRNA expression in colorectal cancer[J]. Sci Rep, 2019,9(1):18065. |